• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.05% Nasdaq Down0.18%

    Rosetta Genomics, Ltd. (ROSG)

    -NasdaqCM
    1.22 Down 0.03(2.40%) May 5, 4:00PM EDT
    ProfileGet Profile for:
    Rosetta Genomics, Ltd.
    10 Plaut Street
    Science Park
    Rehovot, 76706
    Israel - Map
    Phone: 972 73 222 0700
    Fax: 972 73 222 0701
    Website: http://www.rosettagenomics.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Laboratories & Research
    Full Time Employees:52

    Business Summary 

    Rosetta Genomics Ltd. develops and commercializes microRNA-based and other molecular diagnostics. MicroRNAs are a group of genes that are produced using instructions encoded in DNA. The company offers diagnostic tests, including RosettaGX Cancer Origin, a diagnostic for the identification of metastatic cancer; mi-LUNG, a lung cancer classification test for cytology samples; mi-KIDNEY, a kidney tumor classification test for pathology samples; and RosettaGX Reveal, a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate (FNA) samples. It is also developing RosettaGX Reveal V2, a microRNA-based assay for the diagnosis of indeterminate thyroid FNAs; and tissue-based microRNA biomarkers to develop a test for the risk stratification of patients with non-muscle-invasive bladder cancer. The company distributes its products primarily in Australia, Canada, Greece, India, Israel, New Zealand, Qatar, Romania, Saudi Arabia, Singapore, Turkey, and the United Arab Emirates. Rosetta Genomics Ltd. was founded in 2000 and is based in Rehovot, Israel.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Rosetta Genomics, Ltd.

    Key Executives 
     PayExercised
    Mr. Kenneth A. Berlin , 52
    Chief Exec. Officer and Pres
    908.00K0.00
    Mr. Ron Kalfus CPA, 42
    Chief Financial Officer
    241.00K0.00
    Dr. Dganit Bar Ph.D., 47
    Chief Scientific Officer
    253.00K0.00
    Mr. Oded Biran Adv., 37
    Gen. Counsel and Sec.
    306.00K0.00
    Mr. Doug Sites ,
    Exec. VP of Sales & Marketing
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.